| AFCR Events & Activities |
|
5th Sino-US Conference: Personalized Medicine in Cancer Therapy Saturday 13th November - Sunday 14th November, 2010 Hong Kong The Asian Fund for Cancer Research is proud to be a sponsor of the 5th Sino-US Conference: Personalized Medicine in Cancer Therapy, in Nov. 13-14th in Hong Kong. Co-organized by Hong Kong Cancer Institute & Department & Department of Clinical Oncology, the Chinese University of Hong Kong, and the MD Anderson Cancer Center in USA, this conference aims to bring together leading international and regional cancer scientists and researchers to share their experiences in personalized medicine in cancer therapy.
15th Annual Conference of the Chinese Biopharmaceutical Association-USA June 12-13, 2010 AFCR's Chief Development Officer, Sree Kaimal, Ph.D., will present at the 15th Annual Conference of the Chinese Biopharmaceutical Association (CBA)-USA on June 12-13, 2010 in Maryland, the United States. Dr. Kaimal will showcase, in conjunction with AFCR's sister organization and its partners at the Shanghai Bio Corporation, the Tissue Bank Consortium in Asia- a project that, achieved from tremendous efforts and multi-party collaboration, has managed to produce one of the largest tissue banks (and one of the most valuable resources) for scientists searching for a cure. Theme: Biopharmaceutical Medicines: Development and Commercialization without Borders Featured Topics: An Insider's View of the Current State of Biopharmaceutical Development and Commercialization Click here to learn more about 15th Annual Conference of the Chinese Biopharmaceutical Association-USA
Letter From the President December 20, 2007 While looking back at the great progress and achievements of 2007, we want to express our sincere appreciation for your generous support to the Asian Fund for Cancer Research. Without your continued support, AFCR would not have been able to achieve what has been accomplished thus far in the fight against cancer in Hong Kong and throughout Asia. Click HERE to find out the important progress on cancer research we have achieved in the past year.
November 14-16, 2007 The 4th International Think Tank Forum: Anti-Cancer Innovation and Global Collaboration provides a unique opportunity for cancer researchers from the U.S., China, and all of Asia to meet with biopharmaceutical executives and venture fund managers to discuss the latest advances in cancer research and examine ways to accelerate progress against cancer through innovative global collaboration. Click HERE for more information.
Consortium for Globalization of Chinese Medicine
In 2006, AFCR became a proud member of the Consortium for Globalization of Chinese Medicine (CGCM), a Hong Kong-based non-profit international organization that promotes the modernization of TCM. AFCR’s President, Dr. Sujuan Ba, met with CGCM’s Secretary General, Dr. George Lau, in November, 2006, to present AFCR’s support of the globalization of Traditional Chinese Medicine (TCM). AFCR support cancer research programs that focuses on the modernization of TCM by conducting thorough preclinical studies, utilizing highly standardized research materials and protocles, and performing rigorously monitored clinical trials according to the internationally recognized standard, the Good Clinical Practice (ICH-GCP).
International Think-Tank Forum on Anti-Cancer Innovations and Global Collaborations
In 2005, AFCR, in partnership with the Chinese Academy of Medical Sciences and the National Foundation for Cancer Research (NFCR), organized a three-day international conference in Beijing. Over 40 speakers from China, the United States, Canada, Germany, and the United Kingdom plus over two hundred Chinese attendees participated in this “International Think Tank Forum on Anti-Cancer Innovations and Global Collaborations.” During the event, researchers at universities and research hospitals worldwide met with students and business leaders to discuss and address the current challenges in cancer research. Topics discussed included molecular targets and drug discoveries, antibody and immune therapies; genomics, proteomics, and their clinical applications; taking discoveries to the venture community; traditional Chinese medicines for treatment cancer patients; and life science opportunities in China. In acknowledgment to the success of the conference, editors of the international cancer journal, Oncology Research, devoted an entire issue to the conference. Research discoveries presented by the speakers as well as the abstracts presented by the attending Chinese scientists were both published. Several cross-continent collaborations have been initiated as a result of the discussions that took place during the conference. This think tank conference provides an excellent interactive platform for scientists and business leaders to explore promising opportunities for collaboration. |
November 2006
October 2005